EMERYVILLE, Calif., Oct. 25, 2016 -- Amyris, Inc. (Nasdaq:AMRS) will report financial results for the third quarter ended September 30, 2016 after market close on Wednesday, November 2, 2016.
The company will hold its quarterly conference call to discuss these results, as well as provide an update on the company's business and outlook, at 4:30 p.m. ET (1:30 p.m. PT) on Wednesday, November 2, 2016.
Conference Call:
Wednesday, November 2, 2016, 4:30 p.m. ET/1:30 p.m. PT
Dial-in Number:
(866) 516-3867 (U.S. & International)
Access Code: 5584794
Audio Webcast:
A live webcast of the call will be available online on the Amyris website. To listen via live webcast, please visit: http://investors.amyris.com. A replay of the webcast will be available on the Investor Relations section of the Company's website approximately two hours after the conclusion of the call.
About Amyris
Amyris is the integrated renewable products company that is enabling the world’s leading brands to achieve sustainable growth. Amyris applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules and produce specialty ingredients and consumer products. The company is delivering its No Compromise® products across a number of markets, including specialty and performance chemicals, flavors and fragrances, cosmetics ingredients, and pharmaceuticals and nutraceuticals. More information about the company is available at www.amyris.com.
Amyris and the Amyris logo are registered trademarks of Amyris, Inc.
Contact:
Peter DeNardo
Director, Investor Relations and Corporate Communications
Amyris, Inc.
+1 (510) 740-7481
[email protected]
[email protected]


BHP's Incoming CEO Visits China Amid Pricing Dispute with CMRG
Bendigo and Adelaide Bank Posts Strong Q3 Earnings, Announces AI-Driven Job Cuts
NIO ES9 SUV Launch Sends HK Shares Down 7% Despite Bold Pricing Strategy
Bank of America Identifies Top Asia-Pacific Semiconductor Stocks Poised for AI-Driven Growth
Kia Cuts EV Sales Target for 2030 Amid Slowing Demand and U.S. Policy Shifts
Abbott Laboratories Ordered to Pay $53 Million in Premature Infant Formula Lawsuit
Bill Ackman Eyes New Fund to Bet Against Market Complacency
SpaceX IPO: Retail Investors to Play Historic Role in Record-Breaking Public Offering
China's AI Stocks Surge as Zhipu and MiniMax Hit Record Highs
Goldman Sachs, ANZ Cut Oil Forecasts Amid U.S.-Iran Ceasefire Hopes
LG Electronics Posts Record Q1 Revenue Amid Strong Demand and Cost Improvements
Anthropic's Mythos AI Model Sparks Emergency Cybersecurity Meeting With Top U.S. Bank CEOs
Pony.ai, Uber, and Verne Launch Europe's First Commercial Robotaxi Service in Zagreb
Pilots Fear Retaliation for Refusing Middle East Flights Amid Ongoing Conflict
Samsung Electronics Posts Eightfold Profit Surge Driven by AI Chip Demand
U.S. Automakers Push Back Against EU Rules Blocking American Trucks from European Market 



